Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Once-Weekly Semaglutide in Adults with Overweight or ObesityThe New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185Full text available |
2 |
Material Type: Article
|
![]() |
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsThe Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470Full text available |
3 |
Material Type: Article
|
![]() |
Lipase Inhibitors for Obesity: A ReviewBiomedicine & pharmacotherapy, 2020-08, Vol.128, p.110314, Article 110314 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2020.110314 ;PMID: 32485574Full text available |
4 |
Material Type: Article
|
![]() |
Once-Weekly Semaglutide in Adolescents with ObesityThe New England journal of medicine, 2022-12, Vol.387 (24), p.2245-2257 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208601 ;PMID: 36322838Full text available |
5 |
Material Type: Article
|
![]() |
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with ObesityThe New England journal of medicine, 2023-09, Vol.389 (10), p.877-888 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302392 ;PMID: 37351564Full text available |
6 |
Material Type: Article
|
![]() |
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsThe New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941Full text available |
7 |
Material Type: Article
|
![]() |
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysisAnnals of internal medicine, 2016-09, Vol.165 (6), p.409 [Peer Reviewed Journal]ISSN: 1539-3704 ;EISSN: 1539-3704 ;DOI: 10.7326/M15-2455Digital Resources/Online E-Resources |
8 |
Material Type: Article
|
![]() |
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)Obesity (Silver Spring, Md.), 2013-05, Vol.21 (5), p.935-943 [Peer Reviewed Journal]Copyright © 2013 The Obesity Society ;Copyright © 2013 The Obesity Society. ;Copyright © 2013 The Obesity Society 2013 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.20309 ;PMID: 23408728Full text available |
9 |
Material Type: Article
|
![]() |
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight ManagementThe New England journal of medicine, 2010-07, Vol.363 (3), p.245-256 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0909809 ;PMID: 20647200 ;CODEN: NEJMAGFull text available |
10 |
Material Type: Article
|
![]() |
Drug interventions for the treatment of obesity in children and adolescentsCochrane database of systematic reviews, 2016-11, Vol.2020 (3), p.CD012436-CD012436 [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012436 ;PMID: 27899001Full text available |
11 |
Material Type: Article
|
![]() |
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studyThe American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNACFull text available |
12 |
Material Type: Article
|
![]() |
Efficacy and safety of orlistat in controlling the progression of prediabetes to diabetes: A meta-analysis and systematic reviewMedicine (Baltimore), 2024-05, Vol.103 (21), p.e38354-e38354 [Peer Reviewed Journal]Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000038354 ;PMID: 38787971Full text available |
13 |
Material Type: Article
|
![]() |
Antiobesity drug therapyCleveland Clinic journal of medicine, 2021-12, Vol.88 (12), p.657-657 [Peer Reviewed Journal]ISSN: 0891-1150 ;EISSN: 1939-2869 ;DOI: 10.3949/CCJM.88C.12001 ;PMID: 34857599Full text available |
14 |
Material Type: Article
|
![]() |
In Reply: Antiobesity drug therapyCleveland Clinic journal of medicine, 2021-12, Vol.88 (12), p.657-658 [Peer Reviewed Journal]ISSN: 0891-1150 ;EISSN: 1939-2869 ;DOI: 10.3949/ccjm.88c.12002 ;PMID: 34857600Full text available |
15 |
Material Type: Article
|
![]() |
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM TrialThe journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3067-3077 [Peer Reviewed Journal]Copyright © 2011 by The Endocrine Society ;2015 INIST-CNRS ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-1256 ;PMID: 21795446 ;CODEN: JCEMAZFull text available |
16 |
Material Type: Article
|
![]() |
Effectiveness and safety of drugs for obesityBMJ (Online), 2024-03, Vol.384, p.e072686-e072686 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2024BMJ ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-072686 ;PMID: 38527759Full text available |
17 |
Material Type: Article
|
![]() |
Centrally Acting Agents for Obesity: Past, Present, and FutureDrugs (New York, N.Y.), 2018-07, Vol.78 (11), p.1113-1132 [Peer Reviewed Journal]Springer International Publishing AG, part of Springer Nature 2018 ;Copyright Springer Science & Business Media Jul 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-0946-y ;PMID: 30014268Full text available |
18 |
Material Type: Article
|
![]() |
Evolution of pharmacological obesity treatments: focus on adverse side-effect profilesDiabetes, obesity & metabolism, 2016-06, Vol.18 (6), p.558-5702016 John Wiley & Sons Ltd ;2016 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12657 ;PMID: 26936802 ;CODEN: DOMEF6Full text available |
19 |
Material Type: Article
|
![]() |
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trialsThe Lancet (British edition), 2007-11, Vol.370 (9600), p.1706-1713 [Peer Reviewed Journal]Elsevier Ltd ;2007 Elsevier Ltd ;Copyright Elsevier Limited Nov 17-Nov 23, 2007 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)61721-8 ;PMID: 18022033 ;CODEN: LANCAOFull text available |
20 |
Material Type: Article
|
![]() |
Wegovy: FDA approves weight loss drug to cut cardiovascular riskBMJ (Online), 2024-03, Vol.384, p.q642-q642 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2024BMJ ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.q642 ;PMID: 38479760Full text available |